[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6 Enrolled Bill (ENR)]
H.R.6
One Hundred Fifteenth Congress
of the
United States of America
AT THE SECOND SESSION
Begun and held at the City of Washington on Wednesday,
the third day of January, two thousand and eighteen
An Act
To provide for opioid use disorder prevention, recovery, and treatment,
and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,

cd15959935a5d52fe578022d3df262049d8847a5ebe6ccc1bd30c8f7fbec2878

(a) Short Title.--This Act may be cited as the ``Substance Use-
Disorder Prevention that Promotes Opioid Recovery and Treatment for
Patients and Communities Act'' or the ``SUPPORT for Patients and
Communities Act''.
(b) Table of Contents.--The table of contents of this Act is as
follows:

df327a2697f0aad1ecac701780320b3efd7b8cb71888773c3945f20483393444

1109b40e408a1a79536a90eee72384cbae618deffd24bf39865e229e84aea16d

TITLE I

-MEDICAID PROVISIONS TO ADDRESS THE OPIOID CRISIS

syndrome and their mothers; GAO study on gaps in Medicaid
coverage for pregnant and postpartum women with substance use
disorder.

7d6b5175b12988359b0581a42554b9813adc41475e38d3ed9fe6179deb82457f

66abdea1dbdc7c4b0b75d59334b1bee8583d60d11dfb14c7f99f3845e2076d5c

e8fe72ee832766b79f9ba83571e27f81979f66751ce6fafdd5df2d2d5efdce6f

provide housing-related services and supports to individuals
struggling with substance use disorders under Medicaid.

3d9d9fc0be5f369f42c9af38caff857bcd625e689a73056c839b23e2fc5e6b18

strategies to provide housing-related supports under Medicaid.

d3f2a32c8d0a19c4bd7126e0c974b03ba81cb382b20b41e62b34659c57dbb723

opioid use disorder and other substance use disorders.

d9f28e93c0c49f944820f8a8444ee68ebc20048a41fdcf1874f963123d4ef344

TITLE II

-MEDICARE PROVISIONS TO ADDRESS THE OPIOID CRISIS

establish drug management programs for at-risk beneficiaries.

d37c54083f55cc8a5755e4be21f371535775b3cc71b5e86f62f0310b7f8ed5bd

a25d8cb6297102fa2f11d7b9a2538767726903b6f79b338994ad9f80d6a8316e

5eb31c0a141fbc3f096733f1e3ff0b5c09cda3d0e6a5917db95dbbb3442dc7d2

D drug management program for at-risk beneficiaries.

7900cf0fb5d345a8cc6c99cbbebad64890d42c9f5d058f9ca082e31acc0d381a

and MA-PD plans pending investigations of credible allegations
of fraud by pharmacies.
Subtitle A--FDA Provisions
Chapter 1--In General

bf13032786ac1906a510261d5beeea7fc730570c54caff71ba062394e2a084fe

report.
Chapter 2--Stop Counterfeit Drugs by Regulating and Enhancing
Enforcement Now

556e712ea241d32e011c8565611ce9a8692b1a247a0a68a76790bd10d02f2087

TITLE III

-FDA AND CONTROLLED SUBSTANCE PROVISIONS

fc62ca2d1694d49c804d3b4d5c6e12eda826c5bf85b7e0845c05a3e7d6c411a3

28102f4198883ef22d5aaecb94364ae76fb9ce46cd07209c6bd57e3b9ff412b7

Chapter 4--Securing Opioids and Unused Narcotics With Deliberate
Disposal and Packaging

336930ef2245c0cb89d29bf8d9b2af205db819a3fb18839683d797c047b5b6eb

Chapter 5--Postapproval Study Requirements

a9c8ef1f6abeb8a61499345a58d1d42ff19ab52901478a4cc0443f5ccedeb5a5

Subtitle B--Controlled Substance Provisions
Chapter 1--More Flexibility With Respect to Medication-Assisted
Treatment for Opioid Use Disorders

1ff8574aaf43616128be0356d60e8eb7a52b5f3682a5ee5262217a11afc9394c

assisted treatment for opioid use disorders.

35fd1752c55889ec0a19959b39be20d7c02eef8929ec657f59417482300fd079

a4aee70934e704df1f96cf0bf88c66d32d55b0f5ddf4c588af1fdb116b8ab7e0

administered by injection or implantation.
Chapter 2--Empowering Pharmacists in the Fight Against Opioid Abuse

234a24294178e3775aab772a35c1a8f7451861c056b80bf72fd19699c43fa64c

under which a pharmacist may decline to fill a prescription.
Chapter 3--Safe Disposal of Unused Medication

e68125b2024f421a9e2edb2771fded71e8d26f78f68721f034e8b6cc0e9496e9

employees of a qualified hospice program.

f6ac28f544d460a0061225698b0c815354c21397776e23bef86a7eb65db0ac02

Chapter 4--Special Registration for Telemedicine Clarification

3d04f194ce6656a20eee22135a1fdb2f8bdb7e9e4066bfac52297807ed05cf88

telemedicine.
Chapter 5--Synthetic Abuse and Labeling of Toxic Substances

66f6fbaa2ced2fd5d09d609795c3cbd3c9132ec152977a706296d304810eaa11

Chapter 6--Access to Increased Drug Disposal

812fdd98da1b417560881f47e9195ae866cde2ddda6a3eaf4223e167db080a53

Chapter 7--Using Data To Prevent Opioid Diversion

373b37e7412d37abb32a54748f0cecbb552f793d9ceb027f716809ab35367198

64fe1ec0117aa8b20f96532bf17f387604d9916a7073550c2f8336b31f3e9334

6308c2f40403061cdf924c17aa8e7799eef048218a48f69fa225c141fbad6b1c

drug coverage information for purposes of identifying primary
payer situations under the Medicare program.

de4bb7cf088070d4a11915d179e60ebc886632b8a06c242fc1646b249753c6c4

TITLE IV

-OFFSETS

623aef87deffa15b9c1c4d538d2f9efc06f8edd9826f458958ebfbc1b1fe1f7c

products.
Subtitle A--Mandatory Reporting With Respect to Adult Behavioral Health
Measures

0a2da587c1b32a2312b838a789eda58fcc7042737ad14dfc5db1144978e0ef1d

measures.
Subtitle B--Medicaid IMD Additional Info

7ddd716ddfd2003a5d7ab9da5c2d5c4d448dd7eb70eca4fd91da3e62e13490d4

TITLE V

-OTHER MEDICAID PROVISIONS

mental diseases requirements and practices under Medicaid.
Subtitle C--CHIP Mental Health and Substance Use Disorder Parity

b2de4948f2b50251d26257fd0a5543932feb8159bbc1a20044d82c75a2ec6d0c

services for children and pregnant women under the Children's
Health Insurance Program.
Subtitle D--Medicaid Reentry

7bb0d9f77c70c04a29b6ebdd3b1522f2ae811be727285d9f97d01676d4fb1e98

to the community for certain individuals.
Subtitle E--Medicaid Partnership

c8f8309b38b11a71115dd24c07fa4f9eb29b29c536c482ee6377d60b9b8c4115

systems to help in-need patients.
Subtitle F--IMD CARE Act

f0f02867bc383a7911af3b59c296af7eccc3173898bb8f7c60371b232d935567

individuals with substance use disorders who are patients in
certain institutions for mental diseases.
Subtitle G--Medicaid Improvement Fund

a098cd2c7c5fb0952b949580f46fbed5667b38f1bac56bc479e46789cea52ad5

Subtitle A--Testing of Incentive Payments for Behavioral Health
Providers for Adoption and Use of Certified Electronic Health Record
Technology

6f47dc8a67eeae2dda98fc62e87aeaf5b6f85e561cb454c109c8e724a51c5279

for adoption and use of certified electronic health record
technology.
Subtitle B--Abuse Deterrent Access

6d89ccdd6f61026517d4a550fb4deee8d9a69e59f917ea16ed70c70d4edf972e

TITLE VI

-OTHER MEDICARE PROVISIONS

under Medicare.
Subtitle C--Medicare Opioid Safety Education

6df19b6ab0009dd8b9b4a6721bece00e1a82116ac5965e2ea560e7e7036f5cfa

b318d7aad3c12acf5ba5f762354831e23c9dfb940ede39468aa2c14e18826017

Medicaid to prevent opioids addictions and enhance access to
medication-assisted treatment.
Subtitle E--Advancing High Quality Treatment for Opioid Use Disorders in
Medicare

257da159d8fc8788434efd069d48073086c14c64f5a06e71f22b1342dd7312fc

Subtitle F--Responsible Education Achieves Care and Healthy Outcomes for
Users' Treatment

e77588b237c2fd81dfca7f0728ab33d7ca9bb621cf1fd5e2c7d7d665a333dbb9

of opioids.
Subtitle G--Preventing Addiction for Susceptible Seniors

e7b06f066f445fa8d4521501f87b367ec6f5ab517ef8f7d547195b2e030da64e

afc493bcadcd5e7ea3bfb6107449456e9fc406ecfa0b2ab2dcb564a6bf46a452

000d7bf2851bc7f832883b5dd1fa0a6aceff8031933889c41ca75cc515f17391

a3632e4c332932289c9d6ab7e4c7cc46f7703dfa63b57ea6e856eea061bbcd2d

Subtitle H--Expanding Oversight of Opioid Prescribing and Payment

2e38d214a6139f95e483833fbe52ba3d1189bca21c996eac484e4fcb96e2a433

payment, adverse incentives, and data under the Medicare
program.

7a245567ee61bb8d127899dcd05ff432b2b82212388bed57626694d22d481830

Subtitle I--Dr. Todd Graham Pain Management, Treatment, and Recovery

38b0a590c907889af1977feb283882a4fdd5caf9ca554bd1d81cc54564847dfe

outpatient prospective payment system to avoid financial
incentives to use opioids instead of non-opioid alternative
treatments.

6c747e4d6e64e94ddc21879c59b2535762fd3adcaaebc1b3a79528097c047236

treatment in Federally qualified health centers and rural
health clinics.

3265ed9df54efa9930527dcd9095c645692ff79c3455000ceffdbc5127041222

to treat or prevent substance use disorders under Medicare
Advantage plans.

6d4f62a7734244c01a5c206112c5627affeb90d21d701dd9ae11e176759edea1

Medicare and Medicaid Innovation; GAO study and report.

bc896ad160035d731e5bcd78cd0bc229dfae003d559452666831942a62be351d

Subtitle J--Combating Opioid Abuse for Care in Hospitals

0bc4285e2aeba523b48de3e60bb9266c08ab70677eaedc7dd036c7e1a66a370a

disorder prevention for hospitals receiving payment under part
A of the Medicare program.

0873e75c2ac92b31b3afc5e80063a2ad880e917fa88ec5f389c1c7e4eae5f576

and opioid use disorder treatments furnished under the
medicare program and other federal health care programs.

a88d44401300fccb3afedbed2aa7a81a6fac1d1ab65b949923f07da711891718

use; Data collection on perioperative opioid use.

dfe50c831026776c0032d59d036662e3a3b610cffaf4c09ae5a8fea9201d78a1

prescribing guidance for Medicare beneficiaries.
Subtitle K--Providing Reliable Options for Patients and Educational
Resources

e1b26af4a7350607f80a709b6ea957902845cbb04e3d22d2794a21345176b410

drug plans to include information on risks associated with
opioids and coverage of nonpharmacological therapies and
nonopioid medications or devices used to treat pain.

bc8a9b30146634d7e2f1d995a008f2d5739172b9766c9a448eed4aad4a648ebe

plans to provide information on the safe disposal of
prescription drugs.

0a1b10cd8cc1603e53dcb40ef566e0dde3b9d4b96bee7302b39df13c237d0c37

of Healthcare Providers and Systems survey relating to pain
management.
Subtitle L--Fighting the Opioid Epidemic With Sunshine

e5cc94099529f50ca8d13ce3a9e62a04be12efa6a6aed5e610ec59454452296a

640973d8d1732eca489310b19d96ab092745f19c578fdd9a6e0195170309d8d4

Subtitle B--Pilot Program for Public Health Laboratories To Detect
Fentanyl and Other Synthetic Opioids

e5c94ef4b73f4692b8076f1e00262e784e8ed68681129d285ee28864852cb6b4

TITLE VII

-PUBLIC HEALTH PROVISIONS

fentanyl and other synthetic opioids.
Subtitle C--Indexing Narcotics, Fentanyl, and Opioids

aa5ffa3f0ab66ce62d24eb448844df6a077c0c8ad631b18f73658d72ffbf5b26

ef05bb229d8aad727d28fd35ab9faab119f7282485b8102dba0785d56711c116

90efc02ba3a3751a449350086cef9c82c2b657f5af69be38ff3546de43bb1358

2104a1866664b967f6c9619516ede504a9ce0f6403bf4c74921198811ca2f3fd

Subtitle D--Ensuring Access to Quality Sober Living

dd9706839ad6dc37d7767a948f941e7b6070d54e4f554a400cf970f6df79e5bd

Subtitle E--Advancing Cutting Edge Research

83a451630b15279fb9f9089c53f09e8812ec468ad85ea70b51a59528300f9513

4395eda853eb03428f189d087c17fe30e232dfcf3c5eb2e2fc9ef614c384cca2

substance use disorder patient records.
Subtitle G--Protecting Pregnant Women and Infants

50e625a1dbd05c30a7091395b54b56b958d99587b0747befad1e08cd0ab4f9c9

06c98c511d95618b61ba9fbce0bc3158abb4cc50664ff476a5fe57efb64f4b3f

Subtitle H--Substance Use Disorder Treatment Workforce

8712e96dd8772ea901ea4d2a3f828d89930fb82fe1bdc84c0f69d8717395deb3

00557917aab852ebc34b843e8374eb51a3e0456ec9f5dcad1d20f8444de25c5c

8c25e598e94a92cb9cb5fcaf837f0f9fb561fb8185913d5e1cfa7762359f8aee

Subtitle I--Preventing Overdoses While in Emergency Rooms

f019f5cd9ef9000dce88539bdb234f5f41c103be3a4b97bc01631919e224159f

drug overdose patients.
Subtitle J--Alternatives to Opioids in the Emergency Department

cb4e0fa4334c67729478beaa0fda246d5431f3fb076ec269037e28a095e0d82a

program.
Subtitle K--Treatment, Education, and Community Help To Combat Addiction

55e5e6462a0658f95cbbff79404e58a793b394cc7a239c7192513333331c69d8

b94b35becd989da4d9c3df2f578c7d224768169bb234d85f7e69c6f8ec346d8e

Subtitle L--Information From National Mental Health and Substance Use
Policy Laboratory

b49fa2d817e5668b5e1a369131c07fa06b0fa038e4555724b9a66ee1bd5f0ba2

Policy Laboratory.
Subtitle M--Comprehensive Opioid Recovery Centers

cae12a9acbd235ffed3afcfc5e75028987dad62ad2db5658198007a025627551

7c0252844fcfc325b881e3562a3506437e63c137ae40266ebe993e282f4d5026

349dd064a8ef76e1dcf9aad04b52ec5d8fc9e50c7beec960582aa0108991f841

2c1fa7d0670358c3cf28d8dd58aa830841b440fffe83a72a70183b1db4ebcc0c

care for children and youth in educational settings.

fc279e22d7052111b6c9b13c975a06f79a38df84bae35aa867ae23903314159f

abuse.
Subtitle O--Eliminating Opioid Related Infectious Diseases

334dd986fbd4e746eadc4b34400a652b34faa74e77f7d859309250d9b8f9ceb3

education regarding infections associated with illicit drug
use and other risk factors.
Subtitle P--Peer Support Communities of Recovery

e6206a878580d7ac2714eeb1ffce5b4bf9128d2b7e268fbac05d9b6856f8f2f3

Subtitle Q--Creating Opportunities That Necessitate New and Enhanced
Connections That Improve Opioid Navigation Strategies

b9241e6890dec8b23ffbaf46cd2483b9132d5b5a7fde42dcd58ac7afebd605da

Subtitle R--Review of Substance Use Disorder Treatment Providers
Receiving Federal Funding

165009d822097222f2f5f2236d9acdc1bd67ab152d2db46200647c1525a92635

receiving Federal funding.
Subtitle S--Other Health Provisions

44befb5b6c7874939813943b32db1a8cc4ed00c9524eb85c8a200a79c2b3e6a1

e405010850c76fcf2db90936b4554b994000a69db193d7a91558d20d2efa21d8

Subtitle A--Synthetics Trafficking and Overdose Prevention

05e5dff0eee450e2fb4e547dc0f570f07c30fe3bd9ac2d5ff3f0bb49963ae496

15583647d9f348af639f57f07d961b334d97cb763481aa62b32e526037a5ed66

TITLE VIII

-MISCELLANEOUS

clearance requirements and falsity or lack of manifest.

b64157b85d0c9ae0593a775b451286982dca18d01cb47c390f989d0e884015ad

Subtitle B--Opioid Addiction Recovery Fraud Prevention

1db0fa82dc1542cab44cad1f36f328921949a02a32102ea5921e47801a0c5c90

substance use disorder treatment service and products.
Subtitle C--Addressing Economic and Workforce Impacts of the Opioid
Crisis

4114767aa95945a2a081f1d7c2b7a56b4e9d02007d10ffaa09a4708d00bae7e3

Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act — HR. 6

Other Sections